Phase 2 Dose-Rising Study of SOR007 Ointment for Actinic Keratosis
Phase of Trial: Phase II
Latest Information Update: 18 Sep 2018
At a glance
- Drugs Paclitaxel (Primary)
- Indications Actinic keratosis
- Focus Adverse reactions
- Sponsors Dfb Soria
- 18 Sep 2018 Results presented in a DFB Soria media release.
- 18 Sep 2018 Status changed from active, no longer recruiting to completed, according to a DFB Soria media release.
- 16 Jan 2018 Planned End Date changed from 1 Jan 2018 to 1 Mar 2018.